GM-CSF mediates mesenchymal–epithelial cross-talk in pancreatic cancer

Cancer Discovery

Volumn 6, Issue 8, 2016, Pages 886-899

  Waghray, Meghna ^a   Yalamanchili, Malica ^a   Dziubinski, Michele ^a   Zeinali, Mina ^a   Erkkinen, Marguerite ^a   Yang, Huibin ^a   Schradle, Kara A ^a   Urs, Sumithra ^a   Di Magliano, Marina Pasca ^a   Welling, Theodore H ^a   Palmbos, Phillip L ^a,b   Abel, Ethan V ^a   Sahai, Vaibhav ^a,b   Nagrath, Sunitha ^a   Wang, Lidong ^a   Simeone, Diane M ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; VIMENTIN; BIOLOGICAL MARKER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENICITY; CELL CULTURE; CELL DIFFERENTIATION ASSAY; CFU COUNTING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; MESENCHYMAL STEM CELL; METASTASIS POTENTIAL; MOLECULAR INTERACTION; MOUSE; MUTATION RATE; NONHUMAN; PANCREAS ADENOCARCINOMA; PROTEIN EXPRESSION; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION; TUMOR GROWTH; TUMOR INVASION; ANIMAL; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL MOTION; CELL PROLIFERATION; CELL TRANSFORMATION; CYTOLOGY; DISEASE MODEL; EPITHELIAL MESENCHYMAL TRANSITION; GENETICS; IMMUNOPHENOTYPING; MESENCHYMAL STROMA CELL; METABOLISM; METASTASIS; PANCREAS TUMOR; PATHOLOGY; STROMA CELL; TUMOR CELL LINE; TUMOR MICROENVIRONMENT; XENOGRAFT;

ANIMALS; BIOMARKERS; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CYTOKINES; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HETEROGRAFTS; HUMANS; IMMUNOPHENOTYPING; MESENCHYMAL STROMAL CELLS; MICE; NEOPLASM METASTASIS; PANCREATIC NEOPLASMS; STROMAL CELLS; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION; TUMOR MICROENVIRONMENT;

EID: 84982890601     PISSN: 21598274     EISSN: 21598290     Source Type: Journal    
DOI: 10.1158/2159-8290.CD-15-0947     Document Type: Article

References (33)

1. Chen J., Carcamo JM., Borquez-Ojeda O., Erdjument-Bromage H., Tempst P., Golde DW. The laminin receptor modulates granulocyte-macrophage colony-stimulating factor receptor complex formation and modulates its signaling. Proc Natl Acad Sci U S A 2003; 100: 14000–5.
2. Olive KP., Jacobetz MA., Davidson CJ., Gopinathan A., McIntyre D., Honess D., et al. Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 2009. 324. 1457–61.
3. Hwang RF., Moore T., Arumugam T., Ramachandran V., Amos KD., Rivera A., et al. Cancer-associated stromal fibroblasts promote pancreatic tumor progression. Cancer Res 2008. 68. 918–26.
4. Ikenaga N., Ohuchida K., Mizumoto K., Cui L., Kayashima T., Morimatsu K., et al. CD10+ pancreatic stellate cells enhance the progression of pancreatic cancer. Gastroenterology 2010. 139. 1041–51, 51 e1–8.
5. Kikuta K., Masamune A., Watanabe T., Ariga H., Itoh H., Hamada S., et al. Pancreatic stellate cells promote epithelial-mesenchymal transition in pancreatic cancer cells. Biochem Biophys Res Commun 2010; 403: 380–4.
6. Xu Z., Vonlaufen A., Phillips PA., Fiala-Beer E., Zhang X., Yang L., et al. Role of pancreatic stellate cells in pancreatic cancer metastasis. Am J Pathol 2010. 177. 2585–96.
7. Erkan M., Michalski CW., Rieder S., Reiser-Erkan C., Abiatari I., Kolb A., et al. The activated stroma index is a novel and independent prognostic marker in pancreatic ductal adenocarcinoma. Clin Gastroenterol Hepatol 2008. 6. 1155–61.
8. Fujita H., Ohuchida K., Mizumoto K., Nakata K., Yu J., Kayashima T., et al. alpha-Smooth muscle actin expressing stroma promotes an aggressive tumor biology in pancreatic ductal adenocarcinoma. Pancreas 2010. 39. 1254–62.
9. Ozdemir BC., Pentcheva-Hoang T., Carstens JL., Zheng X., Wu CC., Simpson TR., et al. Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Cancer Cell 2014. 25. 719–34.
10. Rhim AD., Oberstein PE., Thomas DH., Mirek ET., Palermo CF., Sastra SA., et al. Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma. Cancer Cell 2014. 25. 735–47.
11. Cao H., Xu W., Qian H., Zhu W., Yan Y., Zhou H., et al. Mesenchymal stem cell-like cells derived from human gastric cancer tissues. Cancer Lett 2009. 274. 61–71.
12. McLean K., Gong Y., Choi Y., Deng N., Yang K., Bai S., et al. Human ovarian carcinoma-associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production. J Clin Invest 2011. 121. 3206–19.
13. Lin JT., Wang JY., Chen MK., Chen HC., Chang TH., Su BW., et al. Colon cancer mesenchymal stem cells modulate the tumorigenicity of colon cancer through interleukin 6. Exp Cell Res 2013. 319. 2216–29.
14. Rhim AD., Mirek ET., Aiello NM., Maitra A., Bailey JM., McAllister F., et al. EMT and dissemination precede pancreatic tumor formation. Cell 2012. 148. 349–61.
15. Seeberger KL., Dufour JM., Shapiro AM., Lakey JR., Rajotte RV., Korbutt GS. Expansion of mesenchymal stem cells from human pancreatic ductal epithelium. Lab Invest 2006. 86. 141–53.
16. Crisan M., Yap S., Casteilla L., Chen CW., Corselli M., Park TS., et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008; 3: 301–13.
17. Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F, Krause D., et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006. 8. 315–7.
18. Prockop DJ., Phinney DG., Bunnell BA. Methods and protocols. Preface. Methods Mol Biol 2008. 449. v–vii.
19. Bayne LJ., Beatty GL., Jhala N., Clark CE., Rhim AD., Stanger B Z, et al. Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer. Cancer Cell 2012. 21. 822–35.
20. Pylayeva-Gupta Y., Lee KE., Hajdu CH., Miller G., Bar-Sagi D. Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia. Cancer Cell 2012. 21. 836–47.
21. Hercus TR., Thomas D., Guthridge MA., Ekert PG., King-Scott J., Parker MW., et al. The granulocyte-macrophage colony-stimulating factor receptor: Linking its structure to cell signaling and its role in disease. Blood 2009. 114. 1289–98.
22. Baldwin GC., Gasson JC., Kaufman SE., Quan SG., Williams RE., Avalos BR., et al. Nonhematopoietic tumor cells express functional GM-CSF receptors. Blood 1989. 73. 1033–7.
23. Martinez-Moczygemba M., Huston DP. Biology of common beta receptor-signaling cytokines: IL-3, IL-5, and GM-CSF. J Allergy Clini Immunol 2003. 112. 653–65. quiz 66.
24. Mani SA., Guo W., Liao MJ., Eaton EN., Ayyanan A., Zhou AY., et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008. 133. 704–15.
25. Li C., Heidt DG., Dalerba P., Burant CF., Zhang L., Adsay V, et al. Identification of pancreatic cancer stem cells. Cancer Res 2007. 67. 1030–7.
26. Mathew E., Brannon AL., Del Vecchio A., Garcia PE., Penny MK., Kane KT., et al. Mesenchymal stem cells promote pancreatic tumor growth by inducing alternative polarization of macrophages. Neoplasia 2016; 18: 142–51.
27. Lonardo E., Frias-Aldeguer J., Hermann PC., Heeschen C. Pancreatic stellate cells form a niche for cancer stem cells and promote their self-renewal and invasiveness. Cell Cycle 2012. 11. 1282–90.
28. Hamada S., Masamune A., Takikawa T., Suzuki N., Kikuta K., Hirota M., et al. Pancreatic stellate cells enhance stem cell-like phenotypes in pancreatic cancer cells. Biochem Biophys Res Commun 2012. 421. 349–54.
29. Hofer EL., Labovsky V., La Russa V., Vallone VF., Honegger AE., Belloc CG., et al. Mesenchymal stromal cells, colony-forming unit fibroblasts, from bone marrow of untreated advanced breast and lung cancer patients suppress fibroblast colony formation from healthy marrow. Stem Cells Dev 2010; 19: 359–70.
30. Karnoub AE., Dash AB., Vo AP., Sullivan A., Brooks MW., Bell GW., et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007. 449. 557–63.
31. Banerjee A., Qian P., Wu ZS., Ren X., Steiner M., Bougen NM., et al. Artemin stimulates radio- and chemo-resistance by promoting TWIST1-BCL-2-dependent cancer stem cell-like behavior in mammary carcinoma cells. J Biol Chem 2012. 287. 42502–15.
32. Levina V., Marrangoni AM., DeMarco R., Gorelik E., Lokshin AE. Drugselected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties. Plos One 2008. 3. e3077.
33. Aliper AM., Frieden-Korovkina VP., Buzdin A., Roumiantsev SA., Zhavoronkov A. A role for G-CSF and GM-CSF in nonmyeloid cancers. Cancer Med 2014. 3. 737–46.